Skip to main content
Top
Published in: Calcified Tissue International 5/2020

Open Access 01-05-2020 | Osteonecrosis | Original Research

Impaired Bone Microarchitecture in Patients with Hereditary Hemochromatosis and Skeletal Complications

Authors: Nico Maximilian Jandl, Tim Rolvien, Tobias Schmidt, Haider Mussawy, Peter Nielsen, Ralf Oheim, Michael Amling, Florian Barvencik

Published in: Calcified Tissue International | Issue 5/2020

Login to get access

Abstract

Hereditary hemochromatosis (HHC) is characterized by excessive intestinal iron absorption resulting in a pathological increase of iron levels. Parenchyma damage may be a consequence of iron deposition in affected organs (e.g., liver, pancreas, gonads) as well as bones and joints, leading to osteoporosis with increased fracture risk and arthropathy. Up to date, it is not known whether HHC can also be considered as a risk factor for osteonecrosis. Likewise, the underlying skeletal changes are unknown regarding, e.g., microstructural properties of bone. We aimed to study the spectrum of skeletal complications in HHC and the possible underlying microarchitectural changes. Therefore, we retrospectively analyzed all patients with HHC (n = 10) presenting in our outpatient clinic for bone diseases. In addition to dual-energy X-ray absorptiometry (DXA), high-resolution peripheral quantitative computed tomography (HR-pQCT) was performed and bone turnover markers, 25-OH-D3, ferritin and transferrin saturation were measured. Cortical volumetric bone mineral density (Ct.BMD) and cortical thickness (Ct.Th) were reduced, whereas trabecular microstructure (Tb.Th) and volumetric bone mineral density (Tb.BMD) were preserved compared to age- and gender-adjusted reference values from the literature. Interestingly, the occurrence of bone complications was age dependent; while younger patients presented with osteonecroses or transient bone marrow edema, patients older than 65 years presented with fractures. Our study provides first insights into altered bone microarchitecture in HHC and sheds new light on the occurrence of osteonecrosis. If available, HR-pQCT is a useful complement to fracture risk assessment and to determine microstructural deterioration and volumetric bone mineralization deficits.
Literature
1.
go back to reference Pietrangelo A (2004) Hereditary hemochromatosis—a new look at an old disease. N Engl J Med 350:2383–2397PubMed Pietrangelo A (2004) Hereditary hemochromatosis—a new look at an old disease. N Engl J Med 350:2383–2397PubMed
2.
go back to reference Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, Dormishian F, Domingo R Jr, Ellis MC, Fullan A, Hinton LM, Jones NL, Kimmel BE, Kronmal GS, Lauer P, Lee VK, Loeb DB, Mapa FA, McClelland E, Meyer NC, Mintier GA, Moeller N, Moore T, Morikang E, Prass CE, Quintana L, Starnes SM, Schatzman RC, Brunke KJ, Drayna DT, Risch NJ, Bacon BR, Wolff RK (1996) A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 13:399–408PubMed Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, Dormishian F, Domingo R Jr, Ellis MC, Fullan A, Hinton LM, Jones NL, Kimmel BE, Kronmal GS, Lauer P, Lee VK, Loeb DB, Mapa FA, McClelland E, Meyer NC, Mintier GA, Moeller N, Moore T, Morikang E, Prass CE, Quintana L, Starnes SM, Schatzman RC, Brunke KJ, Drayna DT, Risch NJ, Bacon BR, Wolff RK (1996) A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 13:399–408PubMed
3.
go back to reference Roetto A, Papanikolaou G, Politou M, Alberti F, Girelli D, Christakis J, Loukopoulos D, Camaschella C (2003) Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat Genet 33:21–22PubMed Roetto A, Papanikolaou G, Politou M, Alberti F, Girelli D, Christakis J, Loukopoulos D, Camaschella C (2003) Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat Genet 33:21–22PubMed
4.
go back to reference Pigeon C, Ilyin G, Courselaud B, Leroyer P, Turlin B, Brissot P, Loreal O (2001) A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem 276:7811–7819PubMed Pigeon C, Ilyin G, Courselaud B, Leroyer P, Turlin B, Brissot P, Loreal O (2001) A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem 276:7811–7819PubMed
5.
go back to reference Fleming RE, Sly WS (2001) Hepcidin: a putative iron-regulatory hormone relevant to hereditary hemochromatosis and the anemia of chronic disease. Proc Natl Acad Sci USA 98:8160–8162PubMed Fleming RE, Sly WS (2001) Hepcidin: a putative iron-regulatory hormone relevant to hereditary hemochromatosis and the anemia of chronic disease. Proc Natl Acad Sci USA 98:8160–8162PubMed
6.
go back to reference Ganz T (2003) Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 102:783–788PubMed Ganz T (2003) Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 102:783–788PubMed
7.
go back to reference Schmidt T, Schmidt C, Schmidt FN, Butscheidt S, Mussawy H, Hubert J, Hawellek T, Oehler N, Barvencik F, Lohse AW, Schinke T, Schramm C, Amling M, Rolvien T (2018) Disease duration and stage influence bone microstructure in patients with primary biliary cholangitis. J Bone Miner Res 33:1011–1019PubMed Schmidt T, Schmidt C, Schmidt FN, Butscheidt S, Mussawy H, Hubert J, Hawellek T, Oehler N, Barvencik F, Lohse AW, Schinke T, Schramm C, Amling M, Rolvien T (2018) Disease duration and stage influence bone microstructure in patients with primary biliary cholangitis. J Bone Miner Res 33:1011–1019PubMed
8.
go back to reference Schmidt T, Schwinge D, Rolvien T, Jeschke A, Schmidt C, Neven M, Butscheidt S, Kriz M, Kunzmann L, Mussawy H, Hubert J, Hawellek T, Ruther W, Oheim R, Barvencik F, Lohse AW, Schramm C, Schinke T, Amling M (2019) Th17 cell frequency is associated with low bone mass in primary sclerosing cholangitis. J Hepatol 70:941–953PubMed Schmidt T, Schwinge D, Rolvien T, Jeschke A, Schmidt C, Neven M, Butscheidt S, Kriz M, Kunzmann L, Mussawy H, Hubert J, Hawellek T, Ruther W, Oheim R, Barvencik F, Lohse AW, Schramm C, Schinke T, Amling M (2019) Th17 cell frequency is associated with low bone mass in primary sclerosing cholangitis. J Hepatol 70:941–953PubMed
9.
go back to reference Guanabens N, Pares A (2018) Osteoporosis in chronic liver disease. Liver Int 38:776–785PubMed Guanabens N, Pares A (2018) Osteoporosis in chronic liver disease. Liver Int 38:776–785PubMed
10.
go back to reference Guggenbuhl P, Deugnier Y, Boisdet JF, Rolland Y, Perdriger A, Pawlotsky Y, Chales G (2005) Bone mineral density in men with genetic hemochromatosis and HFE gene mutation. Osteoporos Int 16:1809–1814PubMed Guggenbuhl P, Deugnier Y, Boisdet JF, Rolland Y, Perdriger A, Pawlotsky Y, Chales G (2005) Bone mineral density in men with genetic hemochromatosis and HFE gene mutation. Osteoporos Int 16:1809–1814PubMed
11.
go back to reference Valenti L, Varenna M, Fracanzani AL, Rossi V, Fargion S, Sinigaglia L (2009) Association between iron overload and osteoporosis in patients with hereditary hemochromatosis. Osteoporos Int 20:549–555PubMed Valenti L, Varenna M, Fracanzani AL, Rossi V, Fargion S, Sinigaglia L (2009) Association between iron overload and osteoporosis in patients with hereditary hemochromatosis. Osteoporos Int 20:549–555PubMed
12.
go back to reference Sinigaglia L, Fargion S, Fracanzani AL, Binelli L, Battafarano N, Varenna M, Piperno A, Fiorelli G (1997) Bone and joint involvement in genetic hemochromatosis: role of cirrhosis and iron overload. J Rheumatol 24:1809–1813PubMed Sinigaglia L, Fargion S, Fracanzani AL, Binelli L, Battafarano N, Varenna M, Piperno A, Fiorelli G (1997) Bone and joint involvement in genetic hemochromatosis: role of cirrhosis and iron overload. J Rheumatol 24:1809–1813PubMed
13.
go back to reference Wolf M, Chertow GM, Macdougall IC, Kaper R, Krop J, Strauss W (2018) Randomized trial of intravenous iron-induced hypophosphatemia. JCI Insight 3:e124486PubMedCentral Wolf M, Chertow GM, Macdougall IC, Kaper R, Krop J, Strauss W (2018) Randomized trial of intravenous iron-induced hypophosphatemia. JCI Insight 3:e124486PubMedCentral
14.
go back to reference Yamasaki K, Hagiwara H (2009) Excess iron inhibits osteoblast metabolism. Toxicol Lett 191:211–215PubMed Yamasaki K, Hagiwara H (2009) Excess iron inhibits osteoblast metabolism. Toxicol Lett 191:211–215PubMed
15.
go back to reference Doyard M, Chappard D, Leroyer P, Roth MP, Loreal O, Guggenbuhl P (2016) Decreased bone formation explains osteoporosis in a genetic mouse model of hemochromatosiss. PLoS ONE 11:e0148292PubMedPubMedCentral Doyard M, Chappard D, Leroyer P, Roth MP, Loreal O, Guggenbuhl P (2016) Decreased bone formation explains osteoporosis in a genetic mouse model of hemochromatosiss. PLoS ONE 11:e0148292PubMedPubMedCentral
16.
go back to reference Guggenbuhl P, Filmon R, Mabilleau G, Basle MF, Chappard D (2008) Iron inhibits hydroxyapatite crystal growth in vitro. Metabolism 57:903–910PubMed Guggenbuhl P, Filmon R, Mabilleau G, Basle MF, Chappard D (2008) Iron inhibits hydroxyapatite crystal growth in vitro. Metabolism 57:903–910PubMed
17.
go back to reference Tsay J, Yang Z, Ross FP, Cunningham-Rundles S, Lin H, Coleman R, Mayer-Kuckuk P, Doty SB, Grady RW, Giardina PJ, Boskey AL, Vogiatzi MG (2010) Bone loss caused by iron overload in a murine model: importance of oxidative stress. Blood 116:2582–2589PubMedPubMedCentral Tsay J, Yang Z, Ross FP, Cunningham-Rundles S, Lin H, Coleman R, Mayer-Kuckuk P, Doty SB, Grady RW, Giardina PJ, Boskey AL, Vogiatzi MG (2010) Bone loss caused by iron overload in a murine model: importance of oxidative stress. Blood 116:2582–2589PubMedPubMedCentral
18.
go back to reference Eyres KS, McCloskey EV, Fern ED, Rogers S, Beneton M, Aaron JE, Kanis JA (1992) Osteoporotic fractures: an unusual presentation of haemochromatosis. Bone 13:431–433PubMed Eyres KS, McCloskey EV, Fern ED, Rogers S, Beneton M, Aaron JE, Kanis JA (1992) Osteoporotic fractures: an unusual presentation of haemochromatosis. Bone 13:431–433PubMed
19.
go back to reference Duquenne M, Rohmer V, Legrand E, Chappard D, Wion Barbot N, Basle MF, Audran M, Bigorgne JC (1996) Spontaneous multiple vertebral fractures revealed primary haemochromatosis. Osteoporos Int 6:338–340PubMed Duquenne M, Rohmer V, Legrand E, Chappard D, Wion Barbot N, Basle MF, Audran M, Bigorgne JC (1996) Spontaneous multiple vertebral fractures revealed primary haemochromatosis. Osteoporos Int 6:338–340PubMed
20.
go back to reference Richette P, Ottaviani S, Vicaut E, Bardin T (2010) Musculoskeletal complications of hereditary hemochromatosis: a case-control study. J Rheumatol 37:2145–2150PubMed Richette P, Ottaviani S, Vicaut E, Bardin T (2010) Musculoskeletal complications of hereditary hemochromatosis: a case-control study. J Rheumatol 37:2145–2150PubMed
21.
go back to reference Sahinbegovic E, Dallos T, Aigner E, Axmann R, Manger B, Englbrecht M, Schoniger-Hekele M, Karonitsch T, Stamm T, Farkas M, Karger T, Stolzel U, Keysser G, Datz C, Schett G, Zwerina J (2010) Musculoskeletal disease burden of hereditary hemochromatosis. Arthritis Rheum 62:3792–3798PubMed Sahinbegovic E, Dallos T, Aigner E, Axmann R, Manger B, Englbrecht M, Schoniger-Hekele M, Karonitsch T, Stamm T, Farkas M, Karger T, Stolzel U, Keysser G, Datz C, Schett G, Zwerina J (2010) Musculoskeletal disease burden of hereditary hemochromatosis. Arthritis Rheum 62:3792–3798PubMed
22.
go back to reference Montgomery KD, Williams JR, Sculco TP, DiCarlo E (1998) Clinical and pathologic findings in hemochromatosis hip arthropathy. Clin Orthop Relat Res 347:179–187 Montgomery KD, Williams JR, Sculco TP, DiCarlo E (1998) Clinical and pathologic findings in hemochromatosis hip arthropathy. Clin Orthop Relat Res 347:179–187
23.
go back to reference Rollot F, Wechsler B, du Boutin le TH, De Gennes C, Amoura Z, Hachulla E, Piette JC (2005) Hemochromatosis and femoral head aseptic osteonecrosis: a nonfortuitous association? J Rheumatol 32:376–378PubMed Rollot F, Wechsler B, du Boutin le TH, De Gennes C, Amoura Z, Hachulla E, Piette JC (2005) Hemochromatosis and femoral head aseptic osteonecrosis: a nonfortuitous association? J Rheumatol 32:376–378PubMed
24.
go back to reference Jaffres R (1966) Bilateral aseptic osteonecrosis of the hip in a patient with hemochromatosis. Rev Rhum Mal Osteoartic 33:269–272PubMed Jaffres R (1966) Bilateral aseptic osteonecrosis of the hip in a patient with hemochromatosis. Rev Rhum Mal Osteoartic 33:269–272PubMed
25.
go back to reference Nielsen P, Fischer R, Engelhardt R, Tondury P, Gabbe EE, Janka GE (1995) Liver iron stores in patients with secondary haemosiderosis under iron chelation therapy with deferoxamine or deferiprone. Br J Haematol 91:827–833PubMed Nielsen P, Fischer R, Engelhardt R, Tondury P, Gabbe EE, Janka GE (1995) Liver iron stores in patients with secondary haemosiderosis under iron chelation therapy with deferoxamine or deferiprone. Br J Haematol 91:827–833PubMed
26.
go back to reference Gardeniers JWM (1991) ARCO committee on terminology and staging (report from the Nijmegen meeting). ARCO News Lett 3:153–159 Gardeniers JWM (1991) ARCO committee on terminology and staging (report from the Nijmegen meeting). ARCO News Lett 3:153–159
27.
go back to reference Assouline-Dayan Y, Chang C, Greenspan A, Shoenfeld Y, Gershwin ME (2002) Pathogenesis and natural history of osteonecrosis. Semin Arthritis Rheum 32:94–124PubMed Assouline-Dayan Y, Chang C, Greenspan A, Shoenfeld Y, Gershwin ME (2002) Pathogenesis and natural history of osteonecrosis. Semin Arthritis Rheum 32:94–124PubMed
28.
go back to reference Milovanovic P, Adamu U, Simon MJ, Rolvien T, Djuric M, Amling M, Busse B (2015) Age- and sex-specific bone structure patterns portend bone fragility in radii and tibiae in relation to osteodensitometry: a high-resolution peripheral quantitative computed tomography study in 385 individuals. J Gerontol A Biol Sci Med Sci 70:1269–1275PubMed Milovanovic P, Adamu U, Simon MJ, Rolvien T, Djuric M, Amling M, Busse B (2015) Age- and sex-specific bone structure patterns portend bone fragility in radii and tibiae in relation to osteodensitometry: a high-resolution peripheral quantitative computed tomography study in 385 individuals. J Gerontol A Biol Sci Med Sci 70:1269–1275PubMed
29.
go back to reference Bouxsein ML, Boyd SK, Christiansen BA, Guldberg RE, Jepsen KJ, Muller R (2010) Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J Bone Miner Res 25:1468–1486PubMed Bouxsein ML, Boyd SK, Christiansen BA, Guldberg RE, Jepsen KJ, Muller R (2010) Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J Bone Miner Res 25:1468–1486PubMed
30.
go back to reference Burt LA, Liang Z, Sajobi TT, Hanley DA, Boyd SK (2016) Sex- and site-specific normative data curves for HR-pQCT. J Bone Miner Res 31:2041–2047PubMed Burt LA, Liang Z, Sajobi TT, Hanley DA, Boyd SK (2016) Sex- and site-specific normative data curves for HR-pQCT. J Bone Miner Res 31:2041–2047PubMed
31.
go back to reference Carroll GJ, Breidahl WH, Bulsara MK, Olynyk JK (2011) Hereditary hemochromatosis is characterized by a clinically definable arthropathy that correlates with iron load. Arthritis Rheum 63:286–294PubMed Carroll GJ, Breidahl WH, Bulsara MK, Olynyk JK (2011) Hereditary hemochromatosis is characterized by a clinically definable arthropathy that correlates with iron load. Arthritis Rheum 63:286–294PubMed
32.
go back to reference Elstob A, Ejindu V, Heron CW, Kiely PDW (2018) MRI ankle and subtalar characteristics in haemochromatosis arthropathy: a case-control study. Clin Radiol 73(323):e321–e328 Elstob A, Ejindu V, Heron CW, Kiely PDW (2018) MRI ankle and subtalar characteristics in haemochromatosis arthropathy: a case-control study. Clin Radiol 73(323):e321–e328
33.
go back to reference Vogiatzi MG, Macklin EA, Fung EB, Vichinsky E, Olivieri N, Kwiatkowski J, Cohen A, Neufeld E, Giardina PJ (2006) Prevalence of fractures among the Thalassemia syndromes in North America. Bone 38:571–575PubMed Vogiatzi MG, Macklin EA, Fung EB, Vichinsky E, Olivieri N, Kwiatkowski J, Cohen A, Neufeld E, Giardina PJ (2006) Prevalence of fractures among the Thalassemia syndromes in North America. Bone 38:571–575PubMed
34.
go back to reference Vogiatzi MG, Macklin EA, Fung EB, Cheung AM, Vichinsky E, Olivieri N, Kirby M, Kwiatkowski JL, Cunningham M, Holm IA, Lane J, Schneider R, Fleisher M, Grady RW, Peterson CC, Giardina PJ, Thalassemia Clinical Research N (2009) Bone disease in thalassemia: a frequent and still unresolved problem. J Bone Miner Res 24:543–557PubMed Vogiatzi MG, Macklin EA, Fung EB, Cheung AM, Vichinsky E, Olivieri N, Kirby M, Kwiatkowski JL, Cunningham M, Holm IA, Lane J, Schneider R, Fleisher M, Grady RW, Peterson CC, Giardina PJ, Thalassemia Clinical Research N (2009) Bone disease in thalassemia: a frequent and still unresolved problem. J Bone Miner Res 24:543–557PubMed
35.
go back to reference Burghardt AJ, Issever AS, Schwartz AV, Davis KA, Masharani U, Majumdar S, Link TM (2010) High-resolution peripheral quantitative computed tomographic imaging of cortical and trabecular bone microarchitecture in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 95:5045–5055PubMedPubMedCentral Burghardt AJ, Issever AS, Schwartz AV, Davis KA, Masharani U, Majumdar S, Link TM (2010) High-resolution peripheral quantitative computed tomographic imaging of cortical and trabecular bone microarchitecture in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 95:5045–5055PubMedPubMedCentral
36.
go back to reference Simao M, Camacho A, Ostertag A, Cohen-Solal M, Pinto IJ, Porto G, Hang Korng E, Cancela ML (2018) Iron-enriched diet contributes to early onset of osteoporotic phenotype in a mouse model of hereditary hemochromatosis. PLoS ONE 13:e0207441PubMedPubMedCentral Simao M, Camacho A, Ostertag A, Cohen-Solal M, Pinto IJ, Porto G, Hang Korng E, Cancela ML (2018) Iron-enriched diet contributes to early onset of osteoporotic phenotype in a mouse model of hereditary hemochromatosis. PLoS ONE 13:e0207441PubMedPubMedCentral
37.
38.
go back to reference Balogh E, Paragh G, Jeney V (2018) Influence of iron on bone homeostasis. Pharmaceuticals (Basel) 11:107 Balogh E, Paragh G, Jeney V (2018) Influence of iron on bone homeostasis. Pharmaceuticals (Basel) 11:107
39.
go back to reference Zarjou A, Jeney V, Arosio P, Poli M, Zavaczki E, Balla G, Balla J (2010) Ferritin ferroxidase activity: a potent inhibitor of osteogenesis. J Bone Miner Res 25:164–172PubMed Zarjou A, Jeney V, Arosio P, Poli M, Zavaczki E, Balla G, Balla J (2010) Ferritin ferroxidase activity: a potent inhibitor of osteogenesis. J Bone Miner Res 25:164–172PubMed
40.
go back to reference Balogh E, Tolnai E, Nagy B Jr, Nagy B, Balla G, Balla J, Jeney V (2016) Iron overload inhibits osteogenic commitment and differentiation of mesenchymal stem cells via the induction of ferritin. Biochim Biophys Acta 1862:1640–1649PubMed Balogh E, Tolnai E, Nagy B Jr, Nagy B, Balla G, Balla J, Jeney V (2016) Iron overload inhibits osteogenic commitment and differentiation of mesenchymal stem cells via the induction of ferritin. Biochim Biophys Acta 1862:1640–1649PubMed
41.
go back to reference Ishii KA, Fumoto T, Iwai K, Takeshita S, Ito M, Shimohata N, Aburatani H, Taketani S, Lelliott CJ, Vidal-Puig A, Ikeda K (2009) Coordination of PGC-1beta and iron uptake in mitochondrial biogenesis and osteoclast activation. Nat Med 15:259–266PubMed Ishii KA, Fumoto T, Iwai K, Takeshita S, Ito M, Shimohata N, Aburatani H, Taketani S, Lelliott CJ, Vidal-Puig A, Ikeda K (2009) Coordination of PGC-1beta and iron uptake in mitochondrial biogenesis and osteoclast activation. Nat Med 15:259–266PubMed
42.
go back to reference Alcantara O, Reddy SV, Roodman GD, Boldt DH (1994) Transcriptional regulation of the tartrate-resistant acid phosphatase (TRAP) gene by iron. Biochem J 298(Pt 2):421–425PubMedPubMedCentral Alcantara O, Reddy SV, Roodman GD, Boldt DH (1994) Transcriptional regulation of the tartrate-resistant acid phosphatase (TRAP) gene by iron. Biochem J 298(Pt 2):421–425PubMedPubMedCentral
43.
go back to reference Diamond T, Stiel D, Posen S (1989) Osteoporosis in hemochromatosis: iron excess, gonadal deficiency, or other factors? Ann Intern Med 110:430–436PubMed Diamond T, Stiel D, Posen S (1989) Osteoporosis in hemochromatosis: iron excess, gonadal deficiency, or other factors? Ann Intern Med 110:430–436PubMed
44.
go back to reference Loreal O, Cavey T, Bardou-Jacquet E, Guggenbuhl P, Ropert M, Brissot P (2014) Iron, hepcidin, and the metal connection. Front Pharmacol 5:128PubMedPubMedCentral Loreal O, Cavey T, Bardou-Jacquet E, Guggenbuhl P, Ropert M, Brissot P (2014) Iron, hepcidin, and the metal connection. Front Pharmacol 5:128PubMedPubMedCentral
45.
go back to reference Adams PC, Bradley C, Frei JV (1991) Hepatic zinc in hemochromatosis. Clin Invest Med 14:16–20PubMed Adams PC, Bradley C, Frei JV (1991) Hepatic zinc in hemochromatosis. Clin Invest Med 14:16–20PubMed
46.
go back to reference Ye Q, Park JE, Gugnani K, Betharia S, Pino-Figueroa A, Kim J (2017) Influence of iron metabolism on manganese transport and toxicity. Metallomics 9:1028–1046PubMedPubMedCentral Ye Q, Park JE, Gugnani K, Betharia S, Pino-Figueroa A, Kim J (2017) Influence of iron metabolism on manganese transport and toxicity. Metallomics 9:1028–1046PubMedPubMedCentral
47.
go back to reference Chappard D, Mabilleau G, Moukoko D, Henric N, Steiger V, Le Nay P, Frin JM, De Bodman C (2015) Aluminum and iron can be deposited in the calcified matrix of bone exostoses. J Inorg Biochem 152:174–179PubMed Chappard D, Mabilleau G, Moukoko D, Henric N, Steiger V, Le Nay P, Frin JM, De Bodman C (2015) Aluminum and iron can be deposited in the calcified matrix of bone exostoses. J Inorg Biochem 152:174–179PubMed
48.
go back to reference Chappard D, Bizot P, Mabilleau G, Hubert L (2016) Aluminum and bone: Review of new clinical circumstances associated with Al(3+) deposition in the calcified matrix of bone. Morphologie 100:95–105PubMed Chappard D, Bizot P, Mabilleau G, Hubert L (2016) Aluminum and bone: Review of new clinical circumstances associated with Al(3+) deposition in the calcified matrix of bone. Morphologie 100:95–105PubMed
49.
go back to reference Bardou-Jacquet E, Laine F, Guggenbuhl P, Morcet J, Jezequel C, Guyader D, Moirand R, Deugnier Y (2017) Worse outcomes of patients with HFE hemochromatosis with persistent increases in transferrin saturation during maintenance therapy. Clin Gastroenterol Hepatol 15:1620–1627PubMed Bardou-Jacquet E, Laine F, Guggenbuhl P, Morcet J, Jezequel C, Guyader D, Moirand R, Deugnier Y (2017) Worse outcomes of patients with HFE hemochromatosis with persistent increases in transferrin saturation during maintenance therapy. Clin Gastroenterol Hepatol 15:1620–1627PubMed
Metadata
Title
Impaired Bone Microarchitecture in Patients with Hereditary Hemochromatosis and Skeletal Complications
Authors
Nico Maximilian Jandl
Tim Rolvien
Tobias Schmidt
Haider Mussawy
Peter Nielsen
Ralf Oheim
Michael Amling
Florian Barvencik
Publication date
01-05-2020
Publisher
Springer US
Published in
Calcified Tissue International / Issue 5/2020
Print ISSN: 0171-967X
Electronic ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-020-00658-7

Other articles of this Issue 5/2020

Calcified Tissue International 5/2020 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.